AMAG PHARMACEUTICALS INC. 4
4 · AMAG PHARMACEUTICALS INC. · Filed May 22, 2017
Insider Transaction Report
Form 4
Deptula Barbara
Director
Transactions
- Award
Common Stock
2017-05-18+4,545→ 14,660 total - Award
Stock Option (Right to Buy)
2017-05-18+10,110→ 10,110 totalExercise: $19.25Exp: 2027-05-18→ Common Stock (10,110 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan (the "Plan") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
- [F2]Not applicable.
- [F3]Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders.